Protein Synthesis Inhibitors II Flashcards
Name the tetracyclines
TDM
Tetracycline
Doxycycline
Minocycline
Lymecycline
Oxytetracyline
What are Tetracycilnes
are crystalline Amphoteric molecules with low solubility: have an acidic and basic functional group–> not soluble
Name the a new drug class derived from Minocycline
Glycylcyclines
Name a Glycylcycline
Tigecycline: IV
Use of Tigecycline
treatment of resistant infections where tetracyclines on their own aren’t enough
Complicated skin, soft tissue, intr-abdominal infections
Uses of Tetracycline
Combination with other agents for treatment of Malaria
DOC in: Rickettsia
Chlamydia
Brucellosis
Mycoplasma infections
Spirochetal infections
Acne: due to its good skin penetrability
Chronic Bronchitis
Doxycyline uses
Prophylaxis of malaria
MOA of Tetracyclines
Bind to 30S subunit–> prevents formation of initiation complex=inhibits codon-anticodon interactions
How do the Tetracyclines enter the cell
move into micro-organisms via passive diffusion through the porins and energy dependent process of active transport
Resistance mechanisms against Tetracyclines
- Decr. intracellular accumulation as a result of decr. influx or active efflux (production of active Efflux pump that pumps the Tetracyclines out of the cell)
- Production of protein that interferes with the binding of Tetracyclines on Ribosome
- Enzymatic inactivation of drug
Admin of Tetracyclines
Orally with variable absorption
*taken with adequate amount of fluid
*Avoid antacids or milk as it prevents their absorption
Why is adequate fluid intake needed with Tetracyclines
to prevent drug capsules from sticking to bottom of Esophagus on mucosal lining=ulceration and pain
*need to remain upright for at least 30mins to prevent occurrence of Ulceration
PK benefits of newer Tetracyclines
Doxycycline and Minocycline
1. more lipid soluble–> near complete absorption in the presence of food
2. less incline to chelate
How do Antacids prevent the absorption of Tetracyclines
They contain Multivalet cations that form insoluble complexes with the Tetracyclins
Distribution of Tetracyclines
widely distributed
*cross placenta and excreted in breast milk
Excretion of newer Tetracyclines
mainly in bile thus its safer for renally impaired people
SEs of Tetracylcines
Cause GIT disruptions: dose-related NV
2. Destruction of normal gut flora=superinfections with Candida
3. Pseudomembranous Colitis: C.difficile can occure
4. Elderly patients: hepatotoxic effects
5. Photsensitivity
6. Deposited in bone and teeth: esp. young children
7. Causes bone growth retardation in children
8. Discolouration of nails+teeth and occasion Enamel Hypoplasia in kids
9. Potentially nephrotoxic effects
10. Reduced efficacy of COC
SEs of Minocycline
Blue-grey pigmentation of skin and pigmentation of acne scars
Vestibular toxicity
SEs of Tiglecycline
Incr. mortality and treatment failure seen
DIs with Tetracyclines
- CYP450 induces like Carbamazepine, phenytoin, barbiturates
- Vit A and other Retinoids: enhanced risk of incr. intracranial Pressure
- COC
Cautions of Tetracylcines
SLE: Minocycline
Myasthenia Graves: have weak neuromuscular blocking effects
Hepatic impairment
Porphyria
Elderly
CIs of Tetracyclines
Pregnancy
Children <8-12 yrs`
What is Chloramphenicol
Broad spectrum Bacteriostatic antibiotic
When is Chloramphenicol used as 1st line drug
rarely because of its potential toxicity: depresses bone marrow
Chloramphenicol is reserved for
severe infections by susceptible organisms due to potential to cause aplastic anemia
Spectrum/Uses of Chloramphenicol
Rickettsial infections: standard drugs CIed
Bacterial meningits: standard drugs CIed
Typhoid fever
Bacterial eye infections: topical
Chloramphenicol is active against
Chlamydia
Mycoplasma infections
Streptococci
Staphylococci
Hemophilus infections
Anaerobes
MOA of Chloramphenicol
powerful inhibitor of Protein Synthesis
Attaches reversibly to 50S subunit–> interferes with MOA of Peptidyl transferases
MOA of Peptidyltransferase
catalyses formation of peptide bind btwn growing peptide and new AA
=peptide cant grow further
Resistance mechanism against Chloramphenicol
Production of Chloramphenicol Acetyltransferase that inactivates the drug
Admin of Chloramphenicol
Chloramphenicol succinate: parenteral
–> highly water soluble where it gets hydrolysed to free Chloramphenicol
Distribution of Chloramphenicol
widely distributed
*high levels in brain and CSF: effective against meningitis
Metabolism of Chloramphenicol
in liver and after Glucuronide formation its excreted in urine
SEs of Chloramphenicol
- Serious IRREVERSIBLE Bone Marrow Depression–> idiosyncratic–> fatal aplastic anemia (esp. topical use)
- Dose-related reversible Bone Marrow Toxicity
- Reduced Efficacy of COC
- Use with great care in babies as ineffective conjugation with Glucuronic acid and excretion of drug cause: GREY BABY SYNDROME
- GIT effects
- Optic or peripheral neuritis
- Hypersensitivity rxns and jaundice
- Inhibits liver enzymes
GREY BABY SYNDROME is characterised by
abdominal distention
cyanosis
vasomotor collapse
Failure to feed
DIs with Chloramphenicol
- Causes CYP450 Inhibition: incr. conc. of Phenytoin, warfarin, sulfonylureases
- CYP450 inducers: decr. efficacy of Chloramphenicol
- Vit B, folic acid and iron: Chloramphenicol may interfere with Hematological response
- COC
Cautions in Chloramphenicol
Impaired hepatic function
Bone marrow depression: cancer, HIV patients
CIs of Chloramphenicol
Allergy
Porphyria
3rd trimester of pregnancy
Neonates
Lactation
Spectrum/Uses of Clindamycin
Susceptible gram +ive infections in patients allergic to Penicillins
Susceptible Staphylococcal and Anaerobic infections
Severe soft tissue infections
Lung Abscesses
Quinsy: not responding to Penicillins
Clindamycin is inactive against
Enterococci